• CDC
  • Heart Failure
  • Cardiovascular Clinical Consult
  • Adult Immunization
  • Hepatic Disease
  • Rare Disorders
  • Pediatric Immunization
  • Implementing The Topcon Ocular Telehealth Platform
  • Weight Management
  • Screening
  • Monkeypox
  • Guidelines
  • Men's Health
  • Psychiatry
  • Allergy
  • Nutrition
  • Women's Health
  • Cardiology
  • Substance Use
  • Pediatrics
  • Kidney Disease
  • Genetics
  • Complimentary & Alternative Medicine
  • Dermatology
  • Endocrinology
  • Oral Medicine
  • Otorhinolaryngologic Diseases
  • Pain
  • Gastrointestinal Disorders
  • Geriatrics
  • Infection
  • Musculoskeletal Disorders
  • Obesity
  • Rheumatology
  • Technology
  • Cancer
  • Nephrology
  • Anemia
  • Neurology
  • Pulmonology

Cardiovascular Disease Prevention in Patients with Obesity: An Expert Perspective

Commentary
Video

Anila Chadha, MD, highlights key preventive strategies to reduce CVD risk in patients with obesity and how to tailor them to address individual patient needs.

Obesity is strongly associated with an increased risk of cardiovascular disease (CVD), making early prevention efforts crucial to reduce the risk of CVD in patients with obesity. How can physicians tailor preventive cardiology interventions to address the individual needs and challenges faced by patients with obesity? That is a question Patient Care Online recently asked Anila Chadha, MD, family physician and obesity medicine physician at Dignity Health Medical Group in Bakersfield, California. “An atherosclerotic cardiovascular disease (ASCVD) risk score should be calculated for each patient,” Dr Chadha said to Patient Care. “Once the risk estimate is calculated, patients can be placed in 1 of 4 risk categories: low, borderline, intermediate, and high. Once we have that information, decision making becomes easier as to whether initiate statin therapy and hypertensive therapy.” If the ASCVD risk score is underestimated or overestimated, then Dr Chadha recommends using a coronary artery calcium score to reclassify the patient’s risk. More details from the conversation in the video above.


Anila Chadha, MD, is also obesity medicine director at Mercy Weight Loss Surgery Program in Bakersfield, CA.

Related Videos
New Research Amplifies Impact of Social Determinants of Health on Cardiometabolic Measures Over Time
Where Should SGLT-2 Inhibitor Therapy Begin? Thoughts from Drs Mikhail Kosiborod and Neil Skolnik
Related Content
© 2024 MJH Life Sciences

All rights reserved.